An extensive portfolio of biosimilars

We offer one of the industry’s largest and most diverse global biosimilars franchises focused on the areas of oncology, immunology, endocrinology, ophthalmology and dermatology. These vital products can help increase access for current and future patients while supporting the sustainability of healthcare systems.

~150
marketing authorizations
85+
countries for our biosimilars